Directory

EFAP/ARS Logos

Program
- Confidentiality
- Assessment


EFAP/ARS
Model


Services
- Advantages
- Library


Funders


Vision/Mission


Key Criteria


Insight EFAP
International


Other ARS


Achievements


Articles


Links


Article Archives

Map Button


Awards
Page 1
Page 2


Home

Email
Phone: 437-4776


FastCounter
by bCentral


View best @
800x600 pixels
Internet Explorer



lower mainland assessment & referral service (efap/ars) width=


MDMA (Ecstasy)

MDMA abuse and the trafficking of MDMA is on the rise, posing serious social concerns. Once confined to major metropolitan areas, MDMA trafficking has now expanded to smaller communities. Teenagers and young adults continue to be the primary targets of sophisticated crime syndicates who are supplying distribution groups with ever-increasing amounts of MDMA tablets. As the trend to consume MDMA in tandem with alcohol and other drugs continues, the harmful effects of the drug will increase exponentially.

EcstasyMDMA (3,4-methylenedioxy-N-methylamphetamine), also referred to as Ecstasy, XTC, Adam, and Essence, is a illegally manufactured variation of mescaline and amphetamine. It is considered a designer drug---a substance on the drug market that is a chemical analogue or variation of another psychoactive drug.

MDMA is marketed as a feel good drug. Devotees say it produces profoundly positive feelings, empathy for others, elimination of anxiety, and extreme relaxation--hence the nickname "hug drug," or "love drug." MDMA is also said to suppress the need to eat, drink, or sleep, enabling club scene users to endure all-night and sometimes two, or three-day parties.

MDMA is taken orally, usually in tablet or capsule form. MDMA tablets are often "stamped" with icons or logos intended to appeal to a young audience. Its effects last approximately four to six hours.

Tablets sold as Ecstasy are not always pure MDMA. As demand for Ecstasy has increased, so has the appearance of Ecstasy "fakes" often containing other substances such as amphetamine, caffeine, codeine, DXM, ephedra/ephedrine, ketamine, MDA, methamphetamine, and PCP. When used alone, MDMA is dangerous. It is even more dangerous when used in combination with other substances, as the physical and psychological effects are difficult to determine or predict.

SHORT TERM EFFECTS: increased heart rate, blood pressure and body temperature; jaw and teeth clenching/muscle tension, hypertension, dehydration, chills and/or sweating, nausea, blurred vision, faintness, dizziness, confusion, insomnia, and paranoia.

MEDICAL COMPLICATIONS:

LARGE DOSE: muscle breakdown, hypothermia, kidney failure and cardiovascular system failure.

LONG TERM USE: depression, sleep disorders, paranoia, drug craving, persistent elevation of anxiety, liver damage, brain damage, paralysis, and possible others pending research.

Note: In 2001, MDMA use among young people jumped an additional 20 percent. Since 1999, teen MDMA use increased by 71 percent. More than 12 percent of teens report trying MDMA at least once in their lives---an increase from 10% in 2000 (a year-to-year increase of 20 percent), 7 percent in 1999 (a 71 percent increase to date) and 5 percent in 1995---an increase of 140 percent from 1995 to 2001. Source: 2001 Partnership Attitude Tracking Study




efap/ars trademark
canadian maple leaf








unauthorized duplication strictly prohibited
lower mainland assessment & referral service©